EB
IRD

Eastern Bank’s Opus Genetics IRD Stock Holding History

Eastern Bank’s Portfolio IRD Stock Details IRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,000
Closed -$982 – 1035
2025
Q1 		$982 Hold
1,000
– – ﹤0.01% 951
2024
Q4 		$1.19K Hold
1,000
– – ﹤0.01% 907
2024
Q3 		$1.31K Buy
+1,000
New +$1.54K ﹤0.01% 881

Other funds holding IRD

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
MBAM
Mink Brook Asset Management West Palm Beach, Florida $179M AUM 37.68% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Eastern Bank's IRD Position: Q2 2025 in Review

Eastern Bank sold out of Opus Genetics (IRD) in Q2 2025, closing a stake of 1,000 shares — an estimated $982 sold.

Eastern Bank first reported a position in IRD in Q3 2024 and held it in 3 quarters. The position peaked at $1.31K in Q3 2024. 43 funds tracked by Wall St. Rank hold IRD as of Q2 2025.

  • Eastern Bank reported no remaining Opus Genetics position as of Q2 2025 after selling out during the quarter.
  • Eastern Bank sold 1,000 Opus Genetics shares in Q2 2025, an estimated $982.
  • Eastern Bank first reported a position in Opus Genetics in Q3 2024 and held it in 3 quarters.
  • Eastern Bank's Opus Genetics position peaked at $1.31K in Q3 2024.
  • 43 funds tracked by Wall St. Rank held Opus Genetics as of Q2 2025.

Based on Eastern Bank's 13F filing for Q2 2025, filed 24 Jul 2025.